Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych VivasSpecialty psychiatry — sexual dysfunction and paraphilias

Psych Vivas · Specialty psychiatry — sexual dysfunction and paraphilias

Sexual dysfunction and paraphilias — structured clinical viva

Fellowship viva spanning PDE5–nitrate contraindication, SSRI sexual SE, pedophilic interest vs disorder, and child-protection ethics.

clinical
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar. A GP asks advice on three linked problems in one clinic letter: (1) a 52-year-old man with diabetes and erectile dysfunction who takes isosorbide mononitrate and wants sildenafil; (2) his partner, a 48-year-old woman on paroxetine with new anorgasmia; (3) their adult son who emailed the GP describing ego-dystonic sexual interest in prepubescent children, denying any offence, requesting 'chemical castration' online. Discuss classification thresholds, medical safety, medication-induced sexual dysfunction, and risk/ethics for the son's disclosure.

Interpretation

Reveal interpretation

Father — ED and nitrates. Sildenafil has strong efficacy evidence for ED but is contraindicated with concurrent nitrates because of severe hypotension risk. Do not prescribe PDE5 inhibitors while he remains on isosorbide mononitrate. Coordinate with cardiology/GP on anti-anginal regimen suitability before any PDE5 trial; address diabetes, vascular risk, alcohol, and relationship factors. Psychogenic-only assumptions are unsafe in a diabetic midlife man.[1]

Partner — paroxetine anorgasmia. Classic serotonergic sexual side-effect. Options: validate, consider dose timing/adjustment if panic/depression allows, switch to a relatively lower-risk antidepressant, or specialist strategies. Separate panic efficacy from sexual tolerability in shared decision-making.[2][6]

Son — pedophilic interest disclosure. Ego-dystonic interest in prepubescent children with help-seeking is clinically serious. Pedophilic disorder requires the interest plus acted urges with children and/or marked distress/interpersonal difficulty — distress is present; offence status needs careful assessment (including online material). Interest ≠ inevitable offending (motivation–facilitation model), but risk assessment and child-protection duties dominate. “Chemical castration” online is not a DIY plan: antiandrogen/GnRH pathways are specialist, consent-based, monitored (WFSBP), and never replace reporting duties or psychological risk work if indicated. Arrange urgent psychiatric/forensic assessment; do not ignore an email disclosure.[3][4][5]

Key points

PDE5 + nitrates

Absolute contraindication — cardiology coordination first.

SSRI orgasm delay

Common, agent/dose-related; switch strategies exist.

Pedophilic interest help-seeking

Assess disorder threshold, risk, and legal duties; specialist pharmacology only in structured care.
[1] [2] [3]

References

  1. [1]Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group N Engl J Med, 1998.PMID 9580646
  2. [2]Montejo AL, Llorca G, Izquierdo JA, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients J Clin Psychiatry, 2001.PMID 11229449
  3. [3]Thibaut F, Cosyns P, Fedoroff JP, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders World J Biol Psychiatry, 2020.PMID 32452729
  4. [4]Seto MC The Motivation-Facilitation Model of Sexual Offending Sex Abuse, 2019.PMID 28715948
  5. [5]Krueger RB, Reed GM, First MB, et al. Proposals for Paraphilic Disorders in the International Classification of Diseases and Related Health Problems, Eleventh Revision (ICD-11) Arch Sex Behav, 2017.PMID 28210933
  6. [6]Clayton AH, El Haddad S, Iluonakhamhe JP, et al. Sexual dysfunction associated with major depressive disorder and antidepressant treatment Expert Opin Drug Saf, 2014.PMID 25148932